The objectives are to define the characteristics of people with HNSCC treated in our area and quantify the impact of the committee on the staging, the change in the initial treatment proposed to determine whether the selection of treatment by the multidisciplinary team (MDT) influences therapeutic compliance.
Observational retrospective study of two cohorts, which aims to analyse the variables in the cohort of patients handled by an MDT with respect to the patients without an MDT. We included all patients with an initial diagnosis of HNSCC at our centre between 2005 and 2012. The MDT cohort comprised those from 01/01/2009 to 31/12/2012. With access to the Pathological Anatomy database, the records of the MDT, the archived and computerised medical history, we collected the endpoints related to the patient (age, sex, ECOG), the tumour (date of diagnosis, location, and TNM stage), the treatment (therapy selected, change in treatment, compliance, reason for default). Definitive sample consists of 408 patients. A descriptive analysis is given of the clinical characteristics of the sample, together with the comparative bivariate analysis of these characteristics in the cohorts.
Our population presents age (mean) 64.2y (SD 12.4), male 82.6%, ECOG
The population served in our area presents clinical characteristics similar to those of other series published in our and other countries. The MDT improved the staging of the tumour before treatment in a statistically significant way. The change in treatment is higher, so as to be statistically significant, when the therapeutic planning is addressed by an MDT. No statistically significant difference was observed in therapeutic compliance rates when treatment was decided by the MDT.
Clinical trial identification
Legal entity responsible for the study
María José Martínez-Ortiz
All authors have declared no conflicts of interest.